Homosalate, Octinoxate, Oxybenzone, Octisalate, Avobenzone
Over-the-CounterNama merek: Advanced Sun Resistance SPF 30
About This Medication
Topical product applied to the skin for localized treatment and symptom relief.
Bahan Aktif
| Bahan | Kekuatan |
|---|---|
| Avobenzone | - |
| Homosalate | - |
| Octinoxate | - |
| Octisalate | - |
| Oxybenzone | - |
Indikasi & Penggunaan
Dosis & Cara Pemberian
Peringatan & Tindakan Pencegahan
Warnings For external use only
Frequently Asked Questions
USES ■ Helps prevent sunburn ■ If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
■ Apply liberally and evenly 15 minutes before sun exposure ■ Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early aging. To decrease this risk, regularly use a sunscreen with broad spectrum SPF of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m. – 2 p.m. • wear long sleeve shirts, pants, hats, and sunglasses ■ Reapply at least every 2 hours ■ …
Warnings For external use only
Homosalate, Octinoxate, Oxybenzone, Octisalate, Avobenzone is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Homosalate, Octinoxate, Oxybenzone, Octisalate, Avobenzone drug label (National Library of Medicine)
- • openFDA — Homosalate, Octinoxate, Oxybenzone, Octisalate, Avobenzone label data (U.S. Food & Drug Administration)
- • NDC Directory — Homosalate, Octinoxate, Oxybenzone, Octisalate, Avobenzone (FDA National Drug Code)
Penafian Medis
Informasi di halaman ini hanya dimaksudkan untuk tujuan pendidikan dan tidak boleh digunakan sebagai pengganti saran medis profesional, diagnosis, atau pengobatan.
Selalu cari saran dari dokter atau penyedia layanan kesehatan berkualifikasi lainnya untuk pertanyaan yang Anda miliki mengenai kondisi medis atau obat.
Sumber data: DailyMed (NLM), openFDA, MFDS